×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| ANG Lifesciences India Limited | 244.57 | -51.91 | 247.29 | -3.98 | 45.5 | |
| VISTA PHARMACEUTICALS LTD. | 26.77 | -13.22 | 25.55 | -0.07 | 43.7 | |
| GKB OPHTHALMICS LTD. | 262.89 | -19.05 | 258.04 | -4.03 | 41.3 |
ANG Lifesciences India Limited, with Security Code 540694, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 71.5 | 58.3 | 45.1 | 31.8 | 50.6 | 29.5 | 17.1 | 34.0 | 16.1 | 32.1 |
| Expenses | 60.3 | 44.2 | 43.0 | 43.5 | 44.9 | 28.3 | 18.8 | 30.2 | 18.1 | 29.7 |
| Operating Profit | 11.3 | 14.2 | 2.1 | -11.6 | 5.7 | 1.3 | -1.7 | 3.8 | -1.9 | 2.5 |
| OPM % | 15.77% | 24.39% | 4.73% | -36.36% | 11.2% | 4.46% | -10.01% | 11.26% | -11.91% | 7.65% |
| Other Income | 0.1 | 0.2 | 0.3 | 9.2 | 0.3 | 0.3 | -0.1 | -1.5 | 1.4 | 0.4 |
| Interest | 3.2 | 3.2 | 2.8 | 1.1 | 1.9 | 2.0 | 2.0 | 3.4 | 1.7 | 1.9 |
| Depreciation | 1.9 | 1.9 | 1.9 | 2.8 | 1.9 | 2.0 | 2.0 | 1.8 | 1.5 | 1.6 |
| Profit before tax | 6.3 | 9.3 | -2.3 | -6.3 | 2.1 | -2.3 | -5.8 | -1.2 | -3.7 | -0.7 |
| Tax % | 47.3% | 18.4% | -30.5% | -20.5% | 25.3% | -9.9% | -21.1% | -23.7% | -26.2% | -60.8% |
| Net Profit | 3.3 | 7.6 | -1.6 | -5.0 | 1.6 | -2.1 | -4.6 | -3.6 | -2.8 | -1.1 |
| EPS in Rs | 3.84 | 2.19 | -1.22 | -3 | 1.28 | -1 | -3.51 | -2.73 | -2.12 | -0.75 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 59.8 | 46.9 | 39.4 | 56.5 | 33.3 | 18.5 | 37.8 | 18.4 | 32.9 | 24.7 |
| Expenses | 50.2 | 44.2 | 49.7 | 49.9 | 31.6 | 20.5 | 34.5 | 20.1 | 30.6 | 26.9 |
| Operating Profit | 9.6 | 2.8 | -10.3 | 6.5 | 1.7 | -1.9 | 3.4 | -1.7 | 2.3 | -2.2 |
| OPM % | 16.1% | 5.9% | -26.1% | 11.6% | 5% | -10.3% | 8.9% | -9.3% | 6.9% | -8.7% |
| Other Income | 0.2 | 0.2 | 9.2 | 0.3 | 0.2 | 0.0 | -1.5 | 1.3 | 0.3 | -0.3 |
| Interest | 3.3 | 3.5 | 1.7 | 2.3 | 2.3 | 2.5 | 3.8 | 2.1 | 2.2 | 2.0 |
| Depreciation | 2.1 | 2.1 | 3.0 | 2.2 | 2.2 | 1.9 | 2.0 | 1.6 | 1.7 | 2.0 |
| Profit before tax | 4.4 | -2.6 | -5.7 | 2.4 | -2.6 | -6.4 | -2.3 | -4.1 | -1.3 | -6.4 |
| Tax % | 40.1% | -31.7% | -19.5% | 25.8% | -11.9% | -6.9% | -10.5% | -25.8% | -62.2% | -18.7% |
| Net Profit | 2.6 | -1.8 | -4.6 | 1.8 | -2.3 | -5.9 | -3.6 | -3.1 | -2.1 | -5.2 |
| EPS in Rs | 2 | -1 | -3 | 1 | -1 | -4 | -2 | -2 | -1 | -3 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 2% |
| 3 Years: | -5% |
| TTM: | -18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 15% |
| 3 Years: | -47% |
| 1 Year: | -47% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -2% |
| TTM: | -23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 15% |
| 3 Years: | -47% |
| 1 Year: | -47% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|